Evonik Corporation
- CMO, CRO
Long-acting injectables (LAIs) and lipid nanoparticles (LNPs). Develops and manufactures complex parenteral drug delivery products, e.g., long-acting microparticles and implants, polymeric nanoparticles, liposomes, and lipid nanoparticles.



